The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Trends in Opioid Analgesic Abuse and Mortality in the United States
Open accessAbstract
BACKGROUND: The use of prescription opioid medications has increased greatly in the United States during the past two decades; in 2010, there were 16,651 opioid-related deaths. In response, hundreds of federal, state, and local interventions have been implemented. We describe trends in the diversion and abuse of prescription opioid analgesics using data through 2013. METHODS: We used five programs from the Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS) System to describe trends between 2002 and 2013 in the diversion and abuse of all products and formulations of six prescription opioid analgesics: oxycodone, hydrocodone, hydromorphone, fentanyl, morphine, and tramadol. The programs gather data from drug-diversion investigators, poison centers, substance-abuse treatment centers, and college students. RESULTS: Prescriptions for opioid analgesics increased substantially from 2002 through 2010 in the United States but then decreased slightly from 2011 through 2013. In general, RADARS System programs reported large increases in the rates of opioid diversion and abuse from 2002 to 2010, but then the rates flattened or decreased from 2011 through 2013. The rate of opioid-related deaths rose and fell in a similar pattern. Reported nonmedical use did not change significantly among college students. CONCLUSIONS: Postmarketing surveillance indicates that the diversion and abuse of prescription opioid medications increased between 2002 and 2010 and plateaued or decreased between 2011 and 2013. These findings suggest that the United States may be making progress in controlling the abuse of opioid analgesics. (Funded by the Denver Health and Hospital Authority.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mowry, J. B., Spyker, D. A., Cantilena, L. R., Bailey, J. E., & Ford, M. (2013) · Clinical Toxicology · doi:10.3109/15563650.2013.863906 · Cited by 456
Effect of Abuse-Deterrent Formulation of OxyContin
Cicero, T. J., Ellis, M. S., & Surratt, H. L. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1204141 · Cited by 336
Self-citationMcCabe, S. E., West, B. T., Teter, C. J., & Boyd, C. J. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2014.03.008 · Cited by 268
Unick, G. J., Rosenblum, D., Mars, S., & Ciccarone, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054496 · Cited by 255
Do Prescription Monitoring Programs Impact State Trends in Opioid Abuse/Misuse?
Reifler, L. M., Droz, D., Bailey, J. E., Schnoll, S. H., Fant, R., Dart, R. C., & Bucher Bartelson, B. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2012.01327.x · Cited by 243
Self-citationPrescription opioid abuse among enrollees into methadone maintenance treatment
Rosenblum, A., Parrino, M., Schnoll, S. H., Fong, C., Maxwell, C., Cleland, C. M., Magura, S., & Haddox, J. D. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.02.012 · Cited by 232
Self-citationFranklin, G. M., Mai, J., Turner, J., Sullivan, M., Wickizer, T., & Fulton‐Kehoe, D. (2012) · American Journal of Industrial Medicine · doi:10.1002/ajim.21998 · Cited by 173
Severtson, S. G., Bartelson, B. B., Davis, J. M., Muñoz, Á., Schneider, M. F., Chilcoat, H. D., COPLAN, P. M., Surratt, H. L., & Dart, R. C. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.04.011 · Cited by 120
Self-citationReductions in prescription opioid diversion following recent legislative interventions in Florida
Surratt, H. L., O’Grady, C. L., Kurtz, S. P., Stivers, Y., Cicero, T. J., Dart, R. C., & Chen, M. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3553 · Cited by 113
Self-citationMonitoring risk: Post marketing surveillance and signal detection
Dart, R. C. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.08.011 · Cited by 69
Self-citation
Research works printed but not linked: 2
- Inciardi JA, 2009, J Opioid Manag, 5, 81, 10.5055/jom.2009.0009 · doi:10.5055/jom.2009.0009
- 10.1016/j.drugalcdep.2007.05.008 · doi:10.1016/j.drugalcdep.2007.05.008
Cited by
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
Compton, W. M., Jones, C. M., & Baldwin, G. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1508490 · Cited by 1,044
Wide Variation and Excessive Dosage of Opioid Prescriptions for Common General Surgical Procedures
Hill, M. V., McMahon, M. L., Stucke, R. S., & Barth, R. J. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000001993 · Cited by 878
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Swarm, R. A., Paice, J. A., Anghelescu, D. L., Are, M., Bruce, J. Y., Buga, S., Chwistek, M., Cleeland, C., Craig, D., Gafford, E., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0038 · Cited by 621
Paice, J. A., Portenoy, R., Lacchetti, C., Campbell, T., Cheville, A., Citron, M., Constine, L. S., Cooper, A., Glare, P., Keefe, F., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.5206 · Cited by 599
Chronic Pain and Mental Health Disorders
Hooten, W. M. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.029 · Cited by 571
Treatment of opioid-use disorders
Schuckit, M. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1604339 · Cited by 540
Drossman, D. A., Tack, J., Ford, A. C., Szigethy, E., Törnblom, H., & Van Oudenhove, L. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.279 · Cited by 470
Manchikanti, L. (2017) · Pain Physician · doi:10.36076/ppj.2017.s92 · Cited by 430
Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004–2014
Winkelman, T. N. A., Villapiano, N., Kozhimannil, K. B., Davis, M. M., & Patrick, S. W. (2018) · Pediatrics · doi:10.1542/peds.2017-3520 · Cited by 373
An Educational Intervention Decreases Opioid Prescribing After General Surgical Operations
Hill, M. V., Stucke, R. S., McMahon, M. L., Beeman, J. L., & Barth, R. J. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002198 · Cited by 367
Han, B., Compton, W. M., Jones, C. M., & Cai, R. (2015) · JAMA · doi:10.1001/jama.2015.11859 · Cited by 366
Opioid Use and Storage Patterns by Patients after Hospital Discharge following Surgery
Bartels, K., Mayes, L. M., Dingmann, C., Bullard, K. J., Hopfer, C. J., & Binswanger, I. A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147972 · Cited by 362
Twin epidemics: The surging rise of methamphetamine use in chronic opioid users
Ellis, M. S., Kasper, Z. A., & Cicero, T. J. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.08.029 · Cited by 355
Self-citationAbdel Shaheed, C., Maher, C. G., Williams, K. A., Day, R., & McLachlan, A. J. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.1251 · Cited by 342
Ray, P., Torck, A., Quigley, L., Wangzhou, A., Neiman, M., Rao, C., Lam, T., Kim, J.-Y., Kim, T. H., Zhang, M. Q., et al. (2018) · Pain · doi:10.1097/j.pain.0000000000001217 · Cited by 342
Alpert, A., Powell, D., & Pacula, R. L. (2018) · American Economic Journal: Economic Policy · doi:10.1257/pol.20170082 · Cited by 323
Kaye, A. D. (2017) · Pain Physician · doi:10.36076/ppj.2017.s109 · Cited by 323
Understanding Links among Opioid Use, Overdose, and Suicide
Bohnert, A. S. B., & Ilgen, M. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1802148 · Cited by 317
US National Trends in Pediatric Deaths From Prescription and Illicit Opioids, 1999-2016
Gaither, J. R., Shabanova, V., & Leventhal, J. M. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.6558 · Cited by 314
The Opioid Epidemic: Crisis and Solutions
Skolnick, P. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052534 · Cited by 307
Singhal, A., Tien, Y.-Y., & Hsia, R. Y. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159224 · Cited by 305
Hadland, S. E., Wharam, J. F., Schuster, M. A., Zhang, F., Samet, J. H., & Larochelle, M. R. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.0745 · Cited by 294
Guideline for Discharge Opioid Prescriptions after Inpatient General Surgical Procedures
Hill, M. V., Stucke, R. S., Billmeier, S. E., Kelly, J. L., & Barth, R. J. (2018) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2017.10.012 · Cited by 288
Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis
Cicero, T. J., Ellis, M. S., & Kasper, Z. A. (2020) · American Journal of Public Health · doi:10.2105/ajph.2019.305412 · Cited by 285
Self-citationGaither, J. R., Leventhal, J. M., Ryan, S. A., & Camenga, D. R. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2016.2154 · Cited by 275
Fairbairn, N., Coffin, P. O., & Walley, A. Y. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.005 · Cited by 274
Rutkow, L., Chang, H.-Y., Daubresse, M., Webster, D. W., Stuart, E. A., & Alexander, G. C. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.3931 · Cited by 262
The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare
Buchmueller, T. C., & Carey, C. (2018) · American Economic Journal: Economic Policy · doi:10.1257/pol.20160094 · Cited by 257
Association of Tramadol With All-Cause Mortality Among Patients With Osteoarthritis
Zeng, C., Dubreuil, M., LaRochelle, M. R., Lu, N., Wei, J., Choi, H. K., Lei, G., & Zhang, Y. (2019) · JAMA · doi:10.1001/jama.2019.1347 · Cited by 256
Saloner, B., & Karthikeyan, S. (2015) · JAMA · doi:10.1001/jama.2015.10345 · Cited by 226
Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10386 · Cited by 222
Defining Optimal Length of Opioid Pain Medication Prescription After Common Surgical Procedures
Scully, R. E., Schoenfeld, A. J., Jiang, W., Lipsitz, S., Chaudhary, M. A., Learn, P. A., Koehlmoos, T., Haider, A. H., & Nguyen, L. L. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2017.3132 · Cited by 215
“Median (IQR) [range] 6 (3-10) [1-45] 6 (3-10) [1-45] 6 (3-10) [1-45] 7 (5-11) [1-44] 8 (4-12) [1-45] 10 (7-15) [1-45] 7 (5-12) [1-44] 7 (4-11) [1-45]”
Inside the nation’s largest mental health institution: a prevalence study in a state prison system
Al-Rousan, T., Rubenstein, L., Sieleni, B., Deol, H., & Wallace, R. B. (2017) · BMC Public Health · doi:10.1186/s12889-017-4257-0 · Cited by 175
“Mental health challenges, substance use disorders, and HIV/AIDS disproportionately affect African-Americans in correctional settings [31], consistent with our findings.”
BackgroundInfluentialHäuser, W., Schug, S., & Furlan, A. D. (2017) · PAIN Reports · doi:10.1097/pr9.0000000000000599 · Cited by 154
Increased use of heroin as an initiating opioid of abuse
Cicero, T. J., Ellis, M. S., & Kasper, Z. A. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.05.030 · Cited by 153
Self-citationSingle-cell RNA-seq uncovers a robust transcriptional response to morphine by glia
Avey, D., Sankararaman, S., Yim, A. K. Y., Barve, R., Milbrandt, J., & Mitra, R. D. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.080 · Cited by 143
“The current epidemic of prescription opioid abuse has contributed to an alarming rise in overdosedeath rates (Dart et al., 2015).”
BackgroundOpioids and their endocrine effects: a systematic review and meta-analysis
de Vries, F., Bruin, M., Lobatto, D. J., Dekkers, O. M., Schoones, J. W., van Furth, W. R., Pereira, A. M., Karavitaki, N., Biermasz, N. R., & Zamanipoor Najafabadi, A. H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz022 · Cited by 139
Barry, D. T., Cutter, C. J., Beitel, M., Kerns, R. D., Liong, C., & Schottenfeld, R. S. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m09963 · Cited by 104
Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993-2014.
Hirschtritt, M. E., Delucchi, K. L., & Olfson, M. (2018) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2017.12.010 · Cited by 93
“…by the NCHS, we grouped visits into mutually exclusive payment categories in descending order: (Pezalla et al., 2017) private-pay or commercial, (Dart et al., 2015) Medicare, (Bachhuber et al., 2016) Medicaid and other government insurance (including the Children's Health Insurance Program), or…”
BackgroundResultInfluentialRowe, C., Santos, G.-M., Vittinghoff, E., Wheeler, E., Davidson, P., & Coffin, P. O. (2016) · Journal of Urban Health · doi:10.1007/s11524-015-0023-8 · Cited by 80
McCabe, S. E., Teter, C. J., Boyd, C. J., Wilens, T. E., & Schepis, T. S. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11958 · Cited by 79
“, women were more likely to report family/relative sources), (2) family/relative sources were associated with self-treatment motives for NMUPD (e.”
BackgroundMethodInfluentialFeingold, D., Brill, S., Goor-Aryeh, I., Delayahu, Y., & Lev-Ran, S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.058 · Cited by 69
Campbell, C. I., Bahorik, A. L., VanVeldhuisen, P., Weisner, C., Rubinstein, A. L., & Ray, G. T. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.01.019 · Cited by 63
Marshall, J. R., Gassner, S. F., Anderson, C. L., Cooper, R. J., Lotfipour, S., & Chakravarthy, B. (2019) · Substance Abuse · doi:10.1080/08897077.2018.1442899 · Cited by 55
Kordrostami, R., Akhgari, M., Ameri, M., Ghadipasha, M., & Aghakhani, K. (2017) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-017-0181-1 · Cited by 55
“One reason for this high amount of drug use is the free availability to drugs without prescription from legitimate pharmacy channels and through non-medical sources [57, 58].”
BackgroundOpioid-prescribing patterns for pediatric patients in the United States.
Groenewald, C. B. (2019) · The Clinical Journal of Pain · doi:10.1097/ajp.0000000000000707 · Cited by 53
McCabe, S. E., Wilens, T. E., Boyd, C. J., Chua, K.-P., Voepel-Lewis, T., & Schepis, T. S. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.11.010 · Cited by 51
Huhn, A. S., Tompkins, D. A., & Dunn, K. E. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.08.019 · Cited by 45
“Misuse of prescription opioids has led to increased prevalence of opioid use disorder (OUD) (Dart et al., 2015; Jones, 2017) and opioid-related deaths (National Center for Health Statistics et al., 2015; Compton et al., 2016; Braden et al., 2017).”
BackgroundCicero, T. J., Ellis, M. S., & Kasper, Z. A. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2016.08.024 · Cited by 28
Self-citationGerak, L. R., & France, C. P. (2016) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.231381 · Cited by 26
Characteristics of high-cost patients diagnosed with opioid abuse
Shei, A., Rice, J. B., Kirson, N. Y., Bodnar, K., Enloe, C. J., Birnbaum, H. G., Holly, P., & Ben-Joseph, R. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.10.902 · Cited by 23
Lam, C., Amarasinghe, G., Zarate-Lopez, N., Fikree, A., Byrne, P., Kiani-Alikhan, S., Gabe, S., & Paine, P. (2023) · Frontline Gastroenterology · doi:10.1136/flgastro-2022-102088 · Cited by 23
Zoorob, M. J. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4417 · Cited by 17
Hepler, S., McKnight, E., Bonny, A., & Kline, D. (2019) · Epidemiology · doi:10.1097/ede.0000000000000978 · Cited by 12
Liu, J., Di, J., Zhang, Y., & Xing, E. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00828-5 · Cited by 10
Evaluation of enzyme-linked immunosorbent assay screening kits for the detection of nitazene analogs
Pacana, A. L., & Skillman, B. N. (2025) · Journal of Forensic Sciences · doi:10.1111/1556-4029.70052 · Cited by 9
Bassiony, M. M., Salah El‐Deen, G. M., Ameen, N., & Mahdy, R. S. (2022) · The American Journal on Addictions · doi:10.1111/ajad.13231 · Cited by 8
Zhou, J., Calip, G. S., Rowan, S., McGregor, J. C., Perez, R. I., Evans, C. T., Gellad, W. F., & Suda, K. J. (2020) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2452 · Cited by 6
Metadata
- Authors
- Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher-Bartelson, B., & Green, J. L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-01-15
- Volume
- 372
- Issue
- 3
- Pages
- 241-248
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2157406381
- Cited by
- 1,137
- References
- 13
- FWCI
- 189.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.